ArticleMolecular and clinical oncology2025

Immunotherapy benefits PD‑L1‑positive gastric‑type endocervical adenocarcinoma: A multicenter, retrospective study.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.